Safilo Group Announces Preliminary 2025 Full-Year Financial Results

Published on January 30, 2026
PADUA, Italy—Safilo Group has announced preliminary results for the financial year ended December 31, 2025. The company reported preliminary sales of €983.4 million for full-year 2025, up 1.8 percent at constant exchange rates, following a fourth quarter that saw an increase of 0.4 percent compared with the same period in 2024. At current exchange rates, sales declined by 1 percent for the year and by 4.6 percent in the quarter, affected by what the company said was weakening of the U.S. dollar against the euro over the course of the year.
Continue reading on website
Other news

Tenpoint Therapeutics Gains FDA Approval for Yuvezzi, a Combination Eye Drop to Treat Presbyopia

January 30, 2026
LONDON and SEATTLE—Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing treatments to improve vision in the aging eye, announced that the U.S. Food and Drug Administration (FDA) has approved Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%, previously known as Brimochol PF, the first and only dual-agent eye drop for the treatment

House of Modo Launches EyeFly, New Audio-Only, Interchangeable Smart Eyewear Brand

January 30, 2026
NEW YORK and MILAN, Italy—House of Modo has announced the launch of EyeFly, a new smart eyewear brand that will debut at Mido 2026. EyeFly is crafted to look and feel like premium everyday eyewear, the company said, and integrates open-ear audio and hands-free connectivity directly into the frame. With EyeFly, users can listen to music and podcasts, take calls or interact with AI assistants withou